ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in ImageneBio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −7 vs. Q4 2024
- Shares held
- 32.7M
- +1.04M (+3.3%) vs. Q4 2024
- Total value
- $41.9M
- −$10.1M (−19.4%) vs. Q4 2024
- New holders
- 3
- 7 more added
- Sold out
- 10
- 20 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 69 | $88 | 0.00% | −30−30.3% | Reduced |
| Farther Finance Advisors, LLC | 108 | $135 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 221 | $283 | 0.00% | −30−12.0% | Reduced |
| BNP Paribas Arbitrage, SA | 315 | $403 | 0.00% | −43,725−99.3% | Reduced |
| Coldstream Capital Management Inc | 525 | $672 | 0.00% | +525 | New |
| JPMorgan Chase & Co | 849 | $1.09K | 0.00% | −154,892−99.5% | Reduced |
| FMR LLC | 5,063 | $6.48K | 0.00% | −5,524−52.2% | Reduced |
| Morgan Stanley | 12,571 | $16.1K | 0.00% | −2,832−18.4% | Reduced |
| Berkshire Asset Management LLC | 20,000 | $21.6K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 16,952 | $21.7K | 0.00% | +583+3.6% | Added |
| Prudential Financial Inc | 26,000 | $33.3K | 0.00% | +7,800+42.9% | Added |
| Dimensional Fund Advisors LP | 38,621 | $49.5K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 56,452 | $72.3K | 0.00% | +43,924+350.6% | Added |
| Northern Trust Corp | 57,565 | $73.7K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 66,177 | $84.7K | 0.00% | −129,134−66.1% | Reduced |
| Millennium Management LLC | 69,684 | $89.2K | 0.00% | −130,000−65.1% | Reduced |
| BBR Partners, LLC | 70,000 | $89.6K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 76,464 | $97.9K | 0.00% | +29,369+62.4% | Added |
| Squarepoint Ops LLC | 77,434 | $99.1K | 0.00% | +33,794+77.4% | Added |
| Two Sigma Investments, LP | 79,422 | $101.7K | 0.00% | −21,356−21.2% | Reduced |
| Citadel Advisors LLC | 79,687 | $102.0K | 0.00% | −681−0.8% | Reduced |
| Deuterium Capital Management, LLC | 80,579 | $103.1K | 0.23% | 00.0% | Unchanged |
| State Street Corp | 92,153 | $118.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 100,660 | $128.8K | 0.00% | +28,804+40.1% | Added |
| Two Sigma Advisers, LP | 151,400 | $193.8K | 0.00% | −6,000−3.8% | Reduced |
| Bridgeway Capital Management, LLC | 153,300 | $196.2K | 0.00% | −500−0.3% | Reduced |
| Acadian Asset Management LLC | 209,568 | $266.0K | 0.00% | −78,800−27.3% | Reduced |
| Jacobs Levy Equity Management, Inc | 245,485 | $314.2K | 0.00% | −81,925−25.0% | Reduced |
| Aldebaran Capital, LLC | 247,795 | $317.2K | 0.30% | +247,795 | New |
| Renaissance Technologies LLC | 294,487 | $376.9K | 0.00% | −35,713−10.8% | Reduced |
| Peapod Lane Capital LLC | 296,437 | $379.4K | 0.43% | −211,431−41.6% | Reduced |
| Geode Capital Management, LLC | 317,091 | $406.0K | 0.00% | −10,871−3.3% | Reduced |
| BlackRock, Inc. | 348,634 | $446.3K | 0.00% | −3,502−1.0% | Reduced |
| Sofinnova Investments, Inc. | 382,616 | $489.7K | 0.04% | 00.0% | Unchanged |
| NEA Management Company, LLC | 600,063 | $768.1K | 0.06% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 800,000 | $1.02M | 0.00% | 00.0% | Unchanged |
| Gilead Sciences, Inc. | 1,159,145 | $1.48M | 0.13% | −849,193−42.3% | Reduced |
| Vanguard Group Inc | 1,383,418 | $1.77M | 0.00% | −1,246−0.1% | Reduced |
| Omega Fund Management, LLC | 2,249,123 | $2.88M | 1.70% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,515,513 | $3.22M | 0.10% | +2,515,513 | New |
| OrbiMed Advisors LLC | 3,539,358 | $4.53M | 0.11% | 00.0% | Unchanged |
| BML Capital Management, LLC | 3,710,803 | $4.75M | 3.84% | +124,937+3.5% | Added |
| BVF Inc | 4,006,564 | $5.13M | 0.21% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 4,091,118 | $5.24M | 1.69% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $6.42M | 1.23% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −72,890−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −72,647−100.0% | Sold out |
| Vazirani Asset Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −21,184−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,934−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,304−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,633−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,503−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −564−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −235−100.0% | Sold out |